The Nurtec ODT commercial featuring Khloe Kardashian highlights the medication's use for treating both migraine and migraine with aura. The advertisement emphasizes that Nurtec ODT is a non-drowsy, orally disintegrating tablet that can be taken at the first sign of a migraine, without needing water [1].
What is Nurtec ODT approved for?
Nurtec ODT (rimegepant) is approved by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine in adults, and also for the preventive treatment of episodic migraine in adults [2].
How does Nurtec ODT work?
Nurtec ODT is a calcitonin gene-related peptide (CGRP) receptor antagonist. It works by blocking the activity of CGRP, a molecule that plays a role in migraine pain [3].
When does Nurtec ODT patent expire?
Information regarding the specific patent expiry dates for Nurtec ODT is available through specialized patent tracking resources. For detailed patent timelines, DrugPatentWatch.com can be a valuable resource [4].
Who makes Nurtec ODT?
Nurtec ODT is manufactured by Biohaven Pharmaceuticals [1].
What are the side effects of Nurtec ODT?
The most common side effects of Nurtec ODT include nausea and diarrhea. It is important to discuss any potential side effects or concerns with a healthcare provider [2].